‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms

 
• By Hannah Daniel, Ryan Nelson, and Elizabeth Orr
US Capitol building on a cloudy day
• Source: Shutterstock

More from Legislation

More from Policy & Regulation